|Articles|December 6, 2002

The Advanstar Advantage (PDF File)

Find out how you can reach key decision-makers in every area of the pharmaceutical business...

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

© putilov_denis - © putilov_denis - stock.adobe.com

Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention

ByMarcela Roy, MA, Lauren Crooks, MSc, Graham Ellis, MD, Alan Kott, MUDR, Dawie Wessels, MD, Elias Ketiar, MD, MRCP

June 4th 2026

For pharmaceutical and life sciences organizations, the strategic imperative is clear: begin immediately with foundation building, scale systematically with measurable milestones, and transform comprehensively toward AI-native data operations. Credit: Stock.Adobe.com/tippapatt.

The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck

ByPartha Anbil,Partha Khot

June 4th 2026

SCOPE X: Why Sponsor-Specific Tech Is Still Holding Sites Back

ByLiz Beatty,Andy Studna, Senior Editor

June 4th 2026

ACT Brief: AI-Driven Enrollment Results, Statistician Standards in Early Phase, and RNA Editing for Kidney Disease

ByAndy Studna, Senior Editor

June 4th 2026

Getting the Foundation Right: Q&A with Sam Hinsley, Phastar

BySam Hinsley,Andy Studna, Senior Editor

June 3rd 2026

The Advanstar Advantage (PDF File)

Related Content

Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention

The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck

SCOPE X: Why Sponsor-Specific Tech Is Still Holding Sites Back

ACT Brief: AI-Driven Enrollment Results, Statistician Standards in Early Phase, and RNA Editing for Kidney Disease

Getting the Foundation Right: Q&A with Sam Hinsley, Phastar

Trending on Applied Clinical Trials Online

Why Real-World Evidence Can No Longer Wait Until After Approval

Three Tensions Transforming Clinical Operations Excellence

SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment

Getting the Foundation Right: Q&A with Sam Hinsley, Phastar

ACT Brief: AI-Driven Enrollment Results, Statistician Standards in Early Phase, and RNA Editing for Kidney Disease